Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Sotera Health Co reported the quarter ended March 31, 2026 results: net income net income of $27 million, EPS $0.09 per diluted share. Guidance reaffirmed.
- Period
- the quarter ended March 31, 2026
- Net income
- net income of $27 million
- EPS
- $0.09 per diluted share
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 • Q1 2026 Adjusted EBITDA (1) increased 10.5%, or 6.9% on a constant currency basis • Q1 2026 Adjusted EPS (1) of $0.18 , an increase of 29% per diluted share • Company reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, both on a constant currency basis
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael B. Petras, Jr. was appointed as Executive Chairman of the Board at Sotera Health Co.
- Action
- appointed
- Role
- Executive Chairman of the Board
Exact text from the filing
the Board appointed Mr. Petras to serve as Executive Chairman of the Board ("Executive Chairman"), as of the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alton Shader was appointed as Chief Executive Officer at Sotera Health Co.
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
the Board, at the recommendation of the Nominating and Corporate Governance Committee, appointed Alton Shader to serve as Chief Executive Officer of the Company ("CEO") and a Class II director of the Board, effective as of May 26, 2026
View on SEC.gov